Carmen Cerchia

, Via D. Montesano 49
Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Corrigendum to "Evaluation of molecular mechanisms of (Z)-3-(pentadec-10'-enyl)-catechol (litreol) and synthetic derivatives as inhibitors of human leukotriene biosynthesis" [Redox Biol. 87 (2025) 103880].

Corrigendum to "Evaluation of molecular mechanisms of (Z)-3-(pentadec-10'-enyl)-catechol (litreol) and synthetic derivatives as inhibitors of human leukotriene biosynthesis" [Redox Biol. 87 (2025) 103880].

Journal: Redox biology

Published: May 22, 2026

In Silico Drug Design and Discovery: Big Data for Small Molecule Design-2nd Edition.

In Silico Drug Design and Discovery: Big Data for Small Molecule Design-2nd Edition.

Journal: Biomolecules

Published: April 10, 2026

Fine-tuning the combination of novel spirocyclic capping moieties and heterocyclic zinc binding groups for selective HDAC6 inhibition: design, synthesis, kinetic and biological studies.

Fine-tuning the combination of novel spirocyclic capping moieties and heterocyclic zinc binding groups for selective HDAC6 inhibition: design, synthesis, kinetic and biological studies.

Journal: European journal of medicinal chemistry

Published: December 23, 2025

ProfhEX: Empowering Early Drug Discovery with Machine Learning-Based Target Profiling and Liability Prediction.

ProfhEX: Empowering Early Drug Discovery with Machine Learning-Based Target Profiling and Liability Prediction.

Journal: Journal of chemical information and modeling

Published: December 08, 2025

Structural and functional characterization of chemically modified antisense oligonucleotides targeting miR-214-3p in endothelial cells.

Structural and functional characterization of chemically modified antisense oligonucleotides targeting miR-214-3p in endothelial cells.

Journal: Bioorganic chemistry

Published: October 16, 2025

Evaluation of molecular mechanisms of (Z)-3-(pentadec-10'-enyl)-catechol (litreol) and synthetic derivatives as inhibitors of human leukotriene biosynthesis.

Evaluation of molecular mechanisms of (Z)-3-(pentadec-10'-enyl)-catechol (litreol) and synthetic derivatives as inhibitors of human leukotriene biosynthesis.

Journal: Redox biology

Published: July 21, 2025

Artificial intelligence in the development of small nucleic acid therapeutics: toward smarter and safer medicines.

Artificial intelligence in the development of small nucleic acid therapeutics: toward smarter and safer medicines.

Journal: Drug discovery today

Published: July 14, 2025

Corrigendum to "A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties" [Eur. J. Med. Chem. 275 (2024) 116567].

Corrigendum to "A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties" [Eur. J. Med. Chem. 275 (2024) 116567].

Journal: European journal of medicinal chemistry

Published: February 13, 2025

Challenging triple negative breast cancer through HDAC6 selective inhibition: Novel cap-group identification, structure-activity relationships, computational and biological studies.

Challenging triple negative breast cancer through HDAC6 selective inhibition: Novel cap-group identification, structure-activity relationships, computational and biological studies.

Journal: European journal of medicinal chemistry

Published: February 13, 2025

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα.

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα.

Journal: Frontiers in pharmacology

Published: August 30, 2024

Methyl-Transferase-Like Protein 16 (METTL16): The Intriguing Journey of a Key Epitranscriptomic Player Becoming an Emerging Biological Target.

Methyl-Transferase-Like Protein 16 (METTL16): The Intriguing Journey of a Key Epitranscriptomic Player Becoming an Emerging Biological Target.

Journal: Journal of medicinal chemistry

Published: August 16, 2024

A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties.

A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties.

Journal: European journal of medicinal chemistry

Published: April 12, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026